EXPERIMENTAL DESIGN APPROACH TO FABRICATE AND OPTIMIZE FLOATING TABLETS OF LEVOFLOXACIN FOR HELICOBACTER PYLORI INFECTION

Authors

  • JAGANATHAN K. The Tamilnadu Dr MGR Medical University, Chennai, Tamilnadu, India 600032
  • VENKATESWARAMURTHY N. Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu, India 638183
  • NEELAMEGARAJAN R. Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu, India 638183 https://orcid.org/0000-0003-1533-3580
  • KANNAN C. Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu, India 638183 https://orcid.org/0000-0001-8071-6540
  • SAMBATHKUMAR R. Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu, India 638183 https://orcid.org/0000-0003-1454-9582

DOI:

https://doi.org/10.22159/ijap.2022v14i6.45809

Keywords:

Levofloxacin, Floating tablet, Helicobacter pylori, Box–Behnken design, HPMC K4 M, HPMC K100M, Xanthan gum

Abstract

Objective: To improve the treatment of H. pylori infection, by achieving the required bactericidal concentrations of antibiotics in the stomach, by delivering the antibiotics to the mucus layer and release the drug at the site of infection for a prolonged period would be significantly more effective than conventional dosage forms.

Methods:  The experimental method of the research was designed to prepare Levofloxacin floating by using Hydroxypropyl Methylcellulose (HPMC K4M),Hydroxypropyl Methylcellulose (HPMC K100M) and Xanthan gum by Three-level Box–Behnken design optimization method. The prepared tablets were evaluated for Thickness, Hardness, Friability, Weight variation, Swelling index (SI), Floating lag time (FLT) and Time required to release 90% of the drug from the tablet (T90%).

Results:  It was found that the Thickness-3.12±0.11mm to 3.28±0.10 mm ,Hardness-4.52±0.36 kg/ cm2 to 4.81±0.24 kg/ cm2, Friability-0.81±0.02g to 0.86±0.12g, Weight variation-480±1.90mg to 523±0.89mg, Swelling index (SI)-61.9±0.624% to 99.95±0.226%, Floating lag time (FLT)-81.12±0.63 s to  119.7±0.567 s and Time required to release 90% of the drug  from the tablet (T90%)-7.0±0.55 h to 10.33±0.289 h.   HPMC K100M and Xanthan gum showed good swelling as compared to HPMC K4M. The study revealed that HPMC K100M grade had a significant effect on drug release.

Conclusion: The developed gastro-floating tablets can extend levofloxacin duration in the stomach and produce a prolonged release effect. The prepared levofloxacin floating tablet oral drug delivery system appears to be a promising choice for the efficient eradication of H. pylori

Downloads

Download data is not yet available.

References

Peek RM,Crabtree JE.Helicobacter infection and gastric neoplasia.J Pathol.2006 ;208(2):233-48.

Kuipers EJ, Thijs JC, Festen HP.The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther.1995;9 Suppl 2:59-69.

Mobley HLT,Mendz GL,Hazell SL,editors.Helicobacter pylori:Physiology and Genetics.Washington (DC):ASM Press;2001.PMID: 21290711.

Take S,Mizuno M,Ishiki K,Kusumoto C,Imada T,Hamada F et al.Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.J Gastroenterol. 2019;55:281-288.

Chey WD,Leontiadis GI,Howden CW,Moss SF.ACG Clinical Guideline:Treatment of Helicobacter pylori Infection.Am J Gastroenterol.2017;112(2):212-239.5.

Malfertheiner P,Megraud F,Morain CA,Gisbert JP,Kuipers EJ,Axon AT et al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.Gut. 2017;66(1):6-30.

El-Shoura SM.Helicobacter pylori,I:ultrastructural sequences of adherence, attachment and penetration into the gastric mucosa. Ultrastruct Pathol.1995;19:323-333.

Engstrand L,Graham DY, Scheynius A, Genta RM. El-zaatari, F. Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol.1997;108:504-509.

Rosa JCM, Hossein Z,Christopher TR.Design and testing in vitro of a bio adhesive and floating drug delivery system for oral application. Int J Pharm.1994;105(1):65-70.

Asnaashari S,Khoei NS,Zarrintan MH,Adibkia K,Javadzadeh Y.Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets. Pharm Dev Technol.2011;16(4):400-407.

Navjot K,Rakesh K,Amita S,Sinha VR.Preparation and evaluation of floating tablets of pregabalin. Drug Dev Ind Pharm.2016;42(4):654-660.

Zaman M,Akhtar F,Baseer A,Hasan SMF, Aman W, Khan A.Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients-based approach. Pak J Pharm. 2021;34(1):057-063.

Numan RS,Abdoon FM.Utility of silver nanoparticles as coloring sensor for determination of levofloxacin in its pure form and pharmaceutical formulations using spectrophotometric technique. AIP Conference Proceedings.2213;020103(2020).

Gevariya HB, Gami S, Patel N.Formulation and characterization of levofloxacin-loaded biodegradable nanoparticles. Asian J Pharm.2011:114-119.

Wan LSC, Paul WS, Heng,Wong LF.Relationship Between Swelling and Drug Release in a Hydrophilic Matrix. Drug Dev Ind Pharm.1993;19(10):1201-1210.

Talukdar MM,Renaat K.Comparative study on xanthan gum and hydroxypropyl methyl cellulose as matrices for controlled-release drug delivery. II. Drug diffusion in hydrated matrices.Int J Pharm.1997;151(1):99-107.

Eliška M,Kateřina K.Hypromellose-A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.J Controlled Release.2020; 324:695-727.

Nokhodchi A,Raja S.The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts.2012;2(4):175-87.

Manjunath,Anjali M.Guar Gum and Its Pharmaceutical and Biomedical Applications. Adv Sci Eng Med.2016;8:1-14.

Siramsetti D,Srinivasa RB.Design and Evaluation of Zolpidem Tartrate Matrix Tablets for Extended Release Using Natural Gums and HPMC K100M.J Appl Pharm Sci.2018;8(07):072-077.

Muhammad AM, Zafar I,Steven HN.Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol Hydrochloride. AAPS Pharm Sci Tech. 2011; 2(1):077-087.

Jaleh V,Naser T,Fatemeh K.Use of Hydrophilic Natural Gums in Formulation of Sustained-release Matrix Tablets of Tramadol Hydrochloride.2006;7(1):E168-E174.

Gangadharappa HV,Rahamath M,Pramod K,Shakeel F.Floating drug delivery system of verapamil hydrochloride using karaya gum and HPMC.Clin Res Regul Aff.2010; 27(1):13-20.

Ju RTC, Nixon,Patel MV.Drug release from hydrophilic matrices.1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci.1995;84:1455-1463.

Sung KC,Nixon PR,Skoug JW,Ju TR, Gao P,Topp EM.Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets.Int J Pharm. 1996;142(1):53-60.

Kim H,Fassihi R.Application of a binary polymer system in drug release rate modulation: I.Characterization of release mechanism.J Pharm Sci.1997;86a:316-322.

Kim H,Fassihi, R.Application of binary polymer system in drug release rate modulation: II.Influence of formulation variables and hydrodynamic conditions on release kinetics.J Pharm Sci.1997;86b:323-328.

Adler J,Jayan A,Melia C D.A method for quantifying differential expansion within hydrating hydrophilic matrices by tracking embedded fluorescent microspheres.J Pharm Sci.1999;88:371-377.

Wan,Lucy S C,Heng, Paul WS,Wong LF.Relationship Between Swelling and Drug Release in a Hydrophilic Matrix. Drug Dev Ind Pharm.1993;19(10):1201-1210.

Talukdar M M,Michoel A,Rombaut P,Kinget R .Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour.Int J Pharm.1996;129(1-2):233-241.

Lin YH,Liang HF,Chung CK,Chen MC,Sung HW.Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials.2005;26:2105-2113.

Fyfe CA,Blazek-Welsh AI.Quantitative NMR imaging study of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets.J Control Release. 2000;68(3):313-33.

Nellore RV,Rekhi GS,Hussain AS,Tillman LG,Augsburger L L.Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration.J Control Release.1998;50(1-3):247-256.

Higuchi T.Mechanism of sustained‐action medication.Theoretical analysis of rate of release of solid drugs dispersed in solid matrices.J Pharm Sci.1963;52(12):1145-1149.

Korsmeyer RW,Gurny R,Doelker E,Buri,Peppas NA.Mechanisms of solute release from porous hydrophilic polymers.Int J Pharm.1983;15(1):25-35.

Rao KR, Lakshmi KR.Design, development and evaluation of clopidogrel bisulfate floating tablets.Int J Pharm Investig.2014;4(1):19-26.

Patel A, Modasiya M, Shah D, Patel V. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.AAPS Pharm SciTech.2009;10(1):310-5.

Loh C, Zhiao, Elkordy A. Amal. Formulation and Evaluation of Different Floating Tablets Containing Metronidazole to Target Stomach.Curr Drug Deliv.2015;12(4):425-443.

Published

23-09-2022

How to Cite

K., J., N., V., R., N., C., K., & R., S. (2022). EXPERIMENTAL DESIGN APPROACH TO FABRICATE AND OPTIMIZE FLOATING TABLETS OF LEVOFLOXACIN FOR HELICOBACTER PYLORI INFECTION. International Journal of Applied Pharmaceutics, 14(6). https://doi.org/10.22159/ijap.2022v14i6.45809

Issue

Section

Original Article(s)

Most read articles by the same author(s)